If you made any changes in Pure these will be visible here soon.

Personal profile


Anton Peleg is Professor of Infectious Diseases and Microbiology and Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University. He is also a research group leader in the Department of Microbiology, Monash University. His research spans clinical to basic research, with a focus on hospital-acquired infections, antimicrobial resistance, infections in immunocompromised hosts and understanding mechanisms of disease caused by hospital pathogens. He has a particular clinical interest in complex infections in highly vulnerable patient groups, including patients with cystic fibrosis, lung and stem cell transplant recipients, and infections in patients with burns or in intensive care.

Clinical activities

Infectious Diseases Physician, Alfred Hospital, Melbourne VIC


  • antibiotic prescribing
  • antibiotic resistance
  • antimicrobial stewardship
  • qualitative research
  • resi
  • bacteria
  • candida
  • epidemiology
  • hematopoietic stem cell transplantation
  • infection
  • microbial drug
  • diabetes
  • immunity
  • glycaemic control
  • hospital-acquired infections
  • antimicrobial resistance
  • infections in immunocompromised hosts

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2021

Research Output 2004 2018

Convergent evolution driven by rifampin exacerbates the global burden of drug-resistant Staphylococcus aureus

Guérillot, R., da Silva, A. G., Monk, I., Giulieri, S., Tomita, T., Alison, E., Porter, J., Pidot, S., Gao, W., Peleg, A. Y., Seemann, T., Stinear, T. P. & Howden, B. P., 1 Jan 2018, In : mSphere. 3, 1, e00550-17.

Research output: Contribution to journalArticleResearchpeer-review

Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model

Bilal, H., Peleg, A. Y., McIntosh, M. P., Styles, I. K., Hirsch, E. B., Landersdorfer, C. B. & Bergen, P. J., 1 Jun 2018, In : Journal of Antimicrobial Chemotherapy. 73, 6, p. 1570-1578 9 p.

Research output: Contribution to journalArticleResearchpeer-review

In vivo atomic force microscopy–infrared spectroscopy of bacteria

Kochan, K., Perez Guaita, D., Pissang, J., Jiang, J-H., Peleg, A. Y., McNaughton, D., Heraud, P. & Wood, B. R., 1 Jan 2018, In : Journal of the Royal Society Interface. 15, 140, 9 p., 20180115.

Research output: Contribution to journalArticleResearchpeer-review

Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients

Rees, V. E., Yadav, R., Rogers, K. E., Bulitta, J. B., Wirth, V., Oliver, A., Boyce, J. D., Peleg, A. Y., Nation, R. L. & Landersdorfer, C. B., 1 Nov 2018, In : Antimicrobial Agents and Chemotherapy. 62, 11, 12 p., e01150-18.

Research output: Contribution to journalArticleResearchpeer-review

Mobile phones and computer keyboards: unlikely reservoirs of multidrug-resistant organisms in the tertiary intensive care unit

Smibert, O. C., Aung, A. K., Woolnough, E., Carter, G. P., Schultz, M. B., Howden, B. P., Seemann, T., Spelman, D., McGloughlin, S. & Peleg, A. Y., 1 Jul 2018, In : Journal of Hospital Infection. 99, 3, p. 295-298 4 p.

Research output: Contribution to journalArticleResearchpeer-review

Activities 2017 2017

  • 1 Membership of industry collaboration/ network

Monash Biomedicine Discovery Institute (Organisational unit)

Trevor Lithgow (Inventor), Matthew James Belousoff (Member), Meredith Anne O'Keeffe (Member), Max Cryle (Member), Ana Traven (Member), John Dallas Boyce (Member), Julian Ian Rood (Member), Fasseli Joseph Coulibaly (Member), Anton Yariv Peleg (Member), Sheena McGowan (Member), Dena Lyras (Member), Philip Robert Heraud (Member)

Activity: Industry, Government and Philanthropy Engagement and PartnershipsMembership of industry collaboration/ network